SitemapImpressumDatenschutzerklärungdeutschenglish
MHH Logo

2009

Assmann G, Kueck O, Kirchhoff T, Rosenthal H, Voswinkel J, Pfreundschuh M, Zeidler H, Wagner AD. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Res Ther 2009;11(5):R140

 

Assmann G, Wagner AD, Monika M, Pfoehler C, Pfreundschuh M, Tilgen W, Roemer K. Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome. Rheumatol Int 2009:DOI: 10.1007/s00296-009-1136-8

 

Burkhardt O, Ellis S, Burhenne H, Kaever V, Hadem J, Kielstein JT, Welte T. High caspofungin levels in alveolar cells of a lung transplant patient with suspected pulmonary aspergillosis. Int J Antimicrob Agents 2009;34(5):491-492

 

Burkhardt O, Kaever V, Burhenne H, Kielstein JT. Extended daily dialysis does not affect the pharmacokinetics of anidulafungin. Int J Antimicrob Agents 2009;34(3):282-283

 

Burkhardt O, Kumar V, Schmidt S, Kielstein JT, Welte T, Derendorf H. Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations. Int J Antimicrob Agents 2009:DOI: 10.1016/j.ijantimicag.2009.09.007

 

Burkhardt O, Rauch K, Kaever V, Hadem J, Kielstein JT, Welte T. Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint. Int J Antimicrob Agents 2009;34(1):101-102

 

Chatzikyrkou C, Haller H, Menne J. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril. Expert Opin Pharmacother 2009;10(11):1833-1840

 

Chatzikyrkou C, Menne J, Haller H. Hypertonologie 2007-2008. Med Klin (Munich) 2009;104(8):614-621

 

Chatzikyrkou C, Menne J, Haller H. How to achieve renal protection in the light of ONTARGET? J Hypertens 2009;27 Suppl 2:S15-7

 

Clajus C, Spiegel J, Broecker V, Chatzikyrkou C, Kielstein JT. Minimal change nephrotic syndrome in an 82 year old patient following a tetanus-diphteria-poliomyelitis-vaccination. BMC Nephrol 2009; 10(1):21

 

David S, Kümpers P, Eisenbach GM, Haller H, Kielstein JT. Prospective evaluation of an in-centre conversion from conventional haemodialysis to an intensified nocturnal strategy. Nephrol Dial Transplant 2009;24(7):2232-2240

 

David S, Kümpers P, Hellpap J, Horn R, Leitolf H, Haller H, Kielstein JT. Angiopoietin 2 and Cardiovascular Disease in Dialysis and Kidney Transplantation. Am J Kidney Dis 2009;53(5):770-778

 

David S, Kümpers P, Lukasz A, Kielstein JT, Haller H, Fliser D. Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin. J Hypertens 2009;27(8):1641-1647

 

David S, Merscher S, Schmidt-Guertler H, Kielstein JT, Kirchhoff T, Meier M. A bitter pill to swallow. Clin Nephrol 2009;72(4):319-321

 

Eisner CB, Faulhaber-Walter R, Wang Y, Levine M, Briggs J, Schnermann J. Gender Differences of Creatinine Excretion in Mice. FASEB J 2009;23(1_MeetingAbstracts):804.18

 

Faulhaber-Walter R, Hafer C, Jahr N, Vahlbruch J, Hoy L, Haller H, Fliser D, Kielstein JT. The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant 2009;24(7):2179-2186

 

Fuhrman B, Gantman A, Khateeb J, Volkova N, Horke S, Kiyan J, Dumler I, Aviram M. Urokinase activates macrophage PON2 gene transcription via the PI3K/ROS/MEK/SREBP-2 signalling cascade mediated by the PDGFR-beta. Cardiovasc Res 2009;84(1):145-154

 

Haller H, Richter N, Brocker V, Gwinner W, Gueler F, Schwarz A. Current problems of kidney transplantation. Internist (Berl) 2009;50(5):523-535

 

Haubitz M, Good DM, Woywodt A, Haller H, Rupprecht H, Theodorescu D, Dakna M, Coon JJ, Mischak H. Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in ANCA associated vasculitis. Mol Cell Proteomics 2009;8(10):2296-2307

 

Ishibe S, Karihaloo A, Ma H, Zhang J, Marlier A, Mitobe M, Togawa A, Schmitt R, Czyczk J, Kashgarian M, Geller DS, Thorgeirsson SS, Cantley LG. Met and the epidermal growth factor receptor act cooperatively to regulate final nephron number and maintain collecting duct morphology. Development 2009;136(2):337-345

 

Kielstein JT. Dosis der Nierenersatztherapie bei akutem Nierenversagen. Dtsch Med Wochenschr 2009;134(34-35):1697-1699

 

Kielstein JT, Burkhardt O. Antibiotic dosing in extended dialysis. Clin Infect Dis 2009;49(12):1963; author reply 1964

 

Kielstein JT, Burkhardt O, Bode-Boeger SM. Dose matters: dose of antibiotics in the critically ill patient depends on the dose of renal replacement therapy. Crit Care Med 2009;37(8):2491; author reply 2491-2

 

Kielstein JT, Fliser D, Veldink H. Asymmetric dimethylarginine and symmetric dimethylarginine: axis of evil or useful alliance? Semin Dial 2009;22(4):346-350

 

Kielstein JT, Hesse G, Bahr MJ, Tsikas D, Terkamp C, Martens-Lobenhoffer J, Manns MP, Haller H, Panning B, Bode-Böger SM, Gebel M. Procedure-related pulmonary hypertension in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection--role of ethanol, hemolysis, asymmetric dimethylarginine, and the nitric oxide system. Crit Care Med 2009;37(4):1483-1485

 

Kielstein JT, Kielstein A. ADMA and the brain: an unfolding story. Am J Hypertens 2009;22(3):240

 

Kielstein JT, Lorenzen J, Kaever V, Burhenne H, Broll M, Hafer C, Burkhardt O. Risk of underdosing of ampicillin/sulbactam in patients with acute kidney injury undergoing extended daily dialysis-a single case. Nephrol Dial Transplant 2009;24(7):2283-2285

 

Kiyan J, Haller H, Dumler I. The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells. Exp Cell Res 2009;315(6):1029-1039

 

Kiyan J, Smith G, Haller H, Dumler I. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts. Biochem J 2009;423(3):343-351

 

Klinge U, Fiebeler A. Analysis of survival curve configuration is relevant for determining pathogenesis and causation. Med Hypotheses 2009;72(5):510-517

 

Klinge U, Theuer S, Krott E, Fiebeler A. Absence of circulating aldosterone attenuates foreign body reaction around surgical sutures. Langenbecks Arch Surg 2009:DOI: 10.1007/s00423-009-0473-0

 

Krausse-Opatz B, Wittkop U, Gutzki FM, Schmidt C, Jürgens-Saathoff B, Meier S, Beckmann B, Takikawa O, Morgan MA, Tsikas D, Stichtenoth DO, Wagner AD, Zeidler H, Köhler L. Free iron ions decrease indoleamine 2,3-dioxygenase expression and reduce IFNgamma-induced inhibition of Chlamydia trachomatis infection. Microb Pathog 2009;46(6):289-297

 

Krückeberg J, Haller H, Matthies HK. Elektronische Prüfungen an der Medizinischen Hochschule Hannover. In: Appelrath HJ, Schulze L [Hrsg.]: Auf dem Weg zu exzellentem E-Learning : Vernetzung und Kooperation der Hochschullehre in Niedersachsen. - Münster u.a. : Waxmann, 2009. - S. 67-75

 

Kümpers P, Hellpap J, David S, Horn R, Leitolf H, Haller H, Haubitz M. Circulating angiopoietin-2 is a marker and potential mediator of endothelial cell detachment in ANCA-associated vasculitis with renal involvement. Nephrol Dial Transplant 2009;24(6):1845-1850

 

Kümpers P, van Meurs M, David S, Molema G, Bijzet J, Lukasz A, Biertz F, Haller H, Zijlstra JG. Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis. Crit Care 2009;13(3):R64

 

Kusch A, Tkachuk S, Tkachuk N, Patecki M, Park JK, Dietz R, Haller H, Dumler I. The tight junction protein ZO-2 mediates proliferation of vascular smooth muscle cells via regulation of Stat1. Cardiovasc Res 2009;83(1):115-122

 

Lorenzen J, Meyer-Olson D, Haubitz M, Witte T, Bange F, Schmidt R, Stoll M. Infection with Mycobacterium genavense in a patient with systemic lupus erythematosus. Clin Rheumatol 2009;28 Suppl 1:S39-41

 

Lorenzen JM, Neunhöffer H, David S, Kielstein JT, Haller H, Fliser D. Angiotensin II receptor blocker and statins lower elevated levels of osteopontin in essential hypertension-Results from the EUTOPIA trial. Atherosclerosis 2009:DOI: 10.1016/j.atherosclerosis.2009.09.009

 

Lorenzen JM, Schoenenberger E, Hafer C, Hoeper M, Kielstein JT. Failed rescue therapy with rapamycin after paraquat intoxication. Clin Toxicol (Phila) 2009:DOI: 10.3109/15563650903376089

 

Lovric S, Becker JU, Kayser D, Wagner A, Haubitz M, Kielstein JT. Fish, flesh and a good red herring: a case of ascending upper limb infection in a renal transplant patient. Clin Nephrol 2009;72(5):402-404

 

Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clement D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009:DOI: 10.1097/HJH.0b013e328333146d

 

Mao M, Liu X, Tian J, Yan S, Lu X, Gueler F, Haller H, Rong S. A novel and knotless technique for heterotopic cardiac transplantation in mice. J Heart Lung Transplant 2009;28(10):1102-1106

 

Meyer AL, Malehsa D, Kuehn C, Bara C, Gras C, Hafer C, Haverich A, Strüber M. HeartMate II implantation in patients with heparin-induced thrombocytopenia type II. Ann Thorac Surg 2009;88(2):674-675

 

Mueller-Deile J, Worthmann K, Saleem MA, Tossidou I, Haller H, Schiffer M. The balance of autocrine VEGF-A and VEGF-C determines podocyte survival. Am J Physiol Renal Physiol 2009:DOI: 10.1152/ajprenal.00275.2009

 

Njau F, Geffers R, Thalmann J, Haller H, Wagner AD. Restriction of Chlamydia pneumoniae replication in human dendritic cell by activation of indoleamine 2,3-dioxygenase. Microbes Infect 2009;11(13):1002-1010

 

Njau F, Ness T, Wittkop U, Pancratz T, Eickhoff M, Hudson AP, Haller H, Wagner AD. No correlation between giant cell arteritis and Chlamydia pneumoniae infection: investigation of 189 patients by standard and improved PCR methods. J Clin Microbiol 2009;47(6):1899-1901

 

Park JK, Mervaala EM, Muller DN, Menne J, Fiebeler A, Luft FC, Haller H. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion. J Hypertens 2009;27(3):599-605

 

Park JK, Theuer S, Kirsch T, Lindschau C, Klinge U, Heuser A, Plehm R, Todiras M, Carmeliet P, Haller H, Luft FC, Muller DN, Fiebeler A. Growth Arrest Specific Protein 6 Participates in DOCA-Induced Target-Organ Damage. Hypertension 2009;54(2):359-364

 

Rihl M, Wagner AD, Bakhsh KA, Rosenthal H, Bernateck M, Köhler L, Zeidler H. Detection of Chlamydial DNA in the Inflamed Sacroiliac Joint of a Patient With Multiple Infections. J Clin Rheumatol 2009;15(4):195-197

 

Ritz E, Viberti GC, Ruilope LM, Rabelink AJ, Izzo JL,Jr, Katayama S, Ito S, Mimran A, Menne J, Rump LC, Januszewicz A, Haller H. Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. Diabetologia 2009:DOI: 10.1007/s00125-009-1577-3

 

Ritz E, Viberti GC, Ruilope LM, Rabelink AJ, Izzo JL,Jr, Katayama S, Ito S, Mimran A, Menne J, Rump LC, Januszewicz A, Haller H. Erratum to: Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. Diabetologia 2009

 

Schiffer L, Kümpers P, Davalos-Misslitz AM, Haubitz M, Haller H, Anders HJ, Witte T, Schiffer M. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). Nephrol Dial Transplant 2009:DOI: 10.1093/ndt/gfp343

 

Schmitt R, Jacobi C, Susnik N, Broecker V, Haller H, Melk A. Ageing mouse kidney: not always the SAME old story. Nephrol Dial Transplant 2009;24(10):3002-3005

 

Schrem H, Barg-Hock H, Strassburg CP, Schwarz A, Klempnauer J. Aftercare for patients with transplanted organs. Dtsch Arztebl Int 2009;106(9):148-156

 

Tossidou I, Starker G, Kruger J, Meier M, Leitges M, Haller H, Schiffer M. PKC-alpha modulates TGF-beta signaling and impairs podocyte survival. Cell Physiol Biochem 2009;24(5-6):627-634

 

Tsikas D. De novo synthesis of trideuteromethyl esters of amino acids for use in GC-MS and GC-tandem MS exemplified for ADMA in human plasma and urine: Standardization, validation, comparison and proof of evidence for their aptitude as internal standards. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877(23):2308-2320

 

van Meurs M, Kümpers P, Ligtenberg JJ, Meertens JH, Molema G, Zijlstra JG. Bench-to-bedside review: Angiopoietin signalling in critical illness - a future target? Crit Care 2009;13(2):207

 

van Meurs M, Kurniati NF, Wulfert FM, Asgeirsdottir SA, de Graaf IA, Satchell SC, Mathieson PW, Jongman RM, Kumpers P, Zijlstra JG, Heeringa P, Molema G. Shock-induced stress induces loss of microvascular endothelial Tie2 in the kidney which is not associated with reduced glomerular barrier function. Am J Physiol Renal Physiol 2009;297(2):F272-81

 

Xavier S, Niranjan T, Krick S, Zhang T, Ju W, Shaw AS, Schiffer M, Bottinger EP. TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes. J Am Soc Nephrol 2009;20(10):2127-2137